IST:MEDTR Statistics

Total Valuation

IST:MEDTR has a market cap or net worth of TRY 4.04 billion. The enterprise value is 3.66 billion.

Market Cap	4.04B
Enterprise Value	3.66B

Important Dates

The next estimated earnings date is Friday, April 4, 2025.

Earnings Date	Apr 4, 2025
Ex-Dividend Date	Jul 28, 2025

Share Statistics

IST:MEDTR has 119.00 million shares outstanding.

Current Share Class	n/a
Shares Outstanding	119.00M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	79.45%
Owned by Institutions (%)	10.80%
Float	24.45M

Valuation Ratios

The trailing PE ratio is 55.00.

PE Ratio	55.00
Forward PE	n/a
PS Ratio	1.93
PB Ratio	1.81
P/TBV Ratio	1.82
P/FCF Ratio	9.98
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.85, with an EV/FCF ratio of 9.04.

EV / Earnings	49.80
EV / Sales	1.75
EV / EBITDA	11.85
EV / EBIT	16.61
EV / FCF	9.04

Financial Position

The company has a current ratio of 3.38, with a Debt / Equity ratio of 0.02.

Current Ratio	3.38
Quick Ratio	1.95
Debt / Equity	0.02
Debt / EBITDA	0.15
Debt / FCF	0.12
Interest Coverage	3.15

Financial Efficiency

Return on equity (ROE) is 3.22% and return on invested capital (ROIC) is 6.40%.

Return on Equity (ROE)	3.22%
Return on Assets (ROA)	5.24%
Return on Invested Capital (ROIC)	6.40%
Return on Capital Employed (ROCE)	9.89%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	728
Asset Turnover	0.76
Inventory Turnover	2.80

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.02% in the last 52 weeks. The beta is 0.50, so IST:MEDTR's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	+28.02%
50-Day Moving Average	42.89
200-Day Moving Average	43.94
Relative Strength Index (RSI)	31.89
Average Volume (20 Days)	438,007

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IST:MEDTR had revenue of TRY 2.09 billion and earned 73.43 million in profits. Earnings per share was 0.62.

Revenue	2.09B
Gross Profit	796.94M
Operating Income	232.51M
Pretax Income	72.60M
Net Income	73.43M
EBITDA	319.52M
EBIT	232.51M
Earnings Per Share (EPS)	0.62

Full Income Statement

Balance Sheet

The company has 434.09 million in cash and 46.88 million in debt, giving a net cash position of 387.22 million or 3.25 per share.

Cash & Cash Equivalents	434.09M
Total Debt	46.88M
Net Cash	387.22M
Net Cash Per Share	3.25
Equity (Book Value)	2.23B
Book Value Per Share	18.74
Working Capital	1.09B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 596.44 million and capital expenditures -191.72 million, giving a free cash flow of 404.72 million.

Operating Cash Flow	596.44M
Capital Expenditures	-191.72M
Free Cash Flow	404.72M
FCF Per Share	3.40

Full Cash Flow Statement

Margins

Gross margin is 38.05%, with operating and profit margins of 11.10% and 3.51%.

Gross Margin	38.05%
Operating Margin	11.10%
Pretax Margin	3.47%
Profit Margin	3.51%
EBITDA Margin	15.26%
EBIT Margin	11.10%
FCF Margin	19.32%

Dividends & Yields

This stock pays an annual dividend of 0.29, which amounts to a dividend yield of 0.82%.

Dividend Per Share	0.29
Dividend Yield	0.82%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	47.14%
Buyback Yield	n/a
Shareholder Yield	0.82%
Earnings Yield	1.82%
FCF Yield	10.02%

Dividend Details

Stock Splits

The last stock split was on February 22, 2022. It was a forward split with a ratio of 3.5.

Last Split Date	Feb 22, 2022
Split Type	Forward
Split Ratio	3.5

Scores

IST:MEDTR has an Altman Z-Score of 6.67.

Altman Z-Score	6.67
Piotroski F-Score	n/a